This is an open ended mutual fund. Seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. Select Pharmaceuticals Index. The Index is designed to measure the performance of U.S. companies in the pharmaceuticals sector using the ICB classification system. A nonconstituent company must have float-adjusted market capitalization of at least $500 million to enter the Index.
0.00
As of 01/31/2023
2022 © Stock Market MBA, Inc.